REFERENCES
- Esters N, Vermeire S, Joossens S, et al. Serological markers for prediction of response to anti-tumor necrosis factor treatment in Crohn's disease. Am J Gastroenterol 2002; 97: 1458–1462, [PUBMED], [INFOTRIEVE]
- van Pesch V, Jadoul M, Lefebvre C, et al. Clinical significance of antiproteinase 3 antibody positivity in cANCA-positive patients. Clin Rheumatol 1999; 18: 279–282, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Vasiliauskas E A, Plevy S E, Landers C J, et al. Perinuclear antineutrophil cytoplasmic antibodies in patients with Crohn's disease define a clinical subgroup. Gastroenterology 1996; 110: 1810–1819, [PUBMED], [INFOTRIEVE], [CSA]
- Locht H, Skogh T, Wiik A. Characterisation of autoantibodies to neutrophil granule constituents among patients with reactive arthritis, rheumatoid arthritis, and ulcerative colitis. Ann Rheum Dis. 2000; 59(11)898–903, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Bang L C, Wiik A, Hoier-Madsen M, et al. Clinical correlates and substrate specificities of antibodies exhibiting neutrophil nuclear reactivity—a methodological study. J Immunol Methods 1995; 187: 287–295, [CROSSREF], [CSA]
- Hauschild S, Schmitt W H, Csernok E, et al. ANCA in systemic vasculitides, collagen vascular diseases, rheumatic disorders and inflammatory bowel diseases. Adv Exp Med Biol 1993; 336: 245–251, [PUBMED], [INFOTRIEVE], [CSA]
- Jennings J G, Chang L, Savige J A. Anti-proteinase 3 antibodies, their characterization and disease associations. Clin Exp Immunol 1994; 95: 251–256, [PUBMED], [INFOTRIEVE], [CSA]
- Khanna D, Aggarwal A, Bhakuni D S, et al. Bactericidal/permeability-increasing protein and cathepsin G are the major antigenic targets of antineutrophil cytoplasmic autoantibodies in systemic sclerosis. J Rheumatol. 2003; 30(6)1248–1252, [PUBMED], [INFOTRIEVE]
- Lesavre P, Noel L H, Gayno S, et al. Atypical autoantigen targets of perinuclear antineutrophil cytoplasm antibodies (P-ANCA): specificity and clinical associations. J Autoimmun 1993; 6: 185–195, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Ooi C J, Lim B L, Cheong W K, et al. Antineutrophil cytoplasmic antibodies (ANCAs) in patients with inflammatory bowel disease show no correlation with proteinase 3, lactoferrin, myeloperoxidase, elastase, cathepsin G and lysozyme: a Singapore study. Ann Acad Med Singapore. 2000; 29(6)704–707, [PUBMED], [INFOTRIEVE], [CSA]
- Savige J A, Chang L, Wilson D, et al. Autoantibodies and target antigens in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides. Rheumatol Int 1996; 16: 109–114, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Schultz D R, Tozman E C. Antineutrophil cytoplasmic antibodies: major autoantigens, pathophysiology, and disease associations. Semin Arthritis Rheum 1995; 25: 143–159, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Sobajima J, Ozaki S, Uesugi H, et al. High mobility group (HMG) non-histone chromosomal proteins HMG1 and HMG2 are significant target antigens of perinuclear anti-neutrophil cytoplasmic antibodies in autoimmune hepatitis [see comments]. Gut 1999; 44: 867–873, [PUBMED], [INFOTRIEVE]
- Cohavy O, Bruckner D, Gordon L K, et al. Colonic bacteria express an ulcerative colitis pANCA-related protein epitope. Infect Immun. 2000; 68(3)1542–1548, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Uesugi H, Ozaki S, Sobajima J, et al. Prevalence and characterization of novel pANCA, antibodies to the high mobility group non-histone chromosomal proteins HMG1 and HMG2, in systemic rheumatic diseases. J Rheumatol 1998; 25: 703–709, [PUBMED], [INFOTRIEVE]
- Vidrich A, Lee J, James E, et al. Segregation of pANCA antigenic recognition by DNase treatment of neutrophils: ulcerative colitis, type 1 autoimmune hepatitis, and primary sclerosing cholangitis. Mayo Clin Proc 1995; 15: 293–299
- Eggena M, Cohavy O, Parseghian M H, et al. Identification of histone H1 as a cognate antigen of the ulcerative colitis-associated marker antibody pANCA. J Autoimmun 2000; 14: 83–97, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Gordon L K, Eggena M, Targan S R, et al. Mast cell and neuroendocrine cytoplasmic autoantigen(s) detected by monoclonal pANCA antibodies. Clin Immunol 2000; 94: 42–50, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Gordon L K, Eggena M, Holland G N, et al. pANCA antibodies in patients with anterior uveitis: identification of a marker antibody usually associated with ulcerative colitis. J Clin Immunol 1998; 18: 264–271, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Nolle B, Coners H, Duncker G. ANCA in ocular inflammatory disorders. Adv Exp Med Biol 1993; 336: 305–307, [PUBMED], [INFOTRIEVE], [CSA]
- Cohavy O, Harth G, Horwitz M, et al. Identification of a novel mycobacterial histone H1 homologue (HupB) as an antigenic target of pANCA monoclonal antibody and serum immunoglobulin A from patients with Crohn's disease. Infect Immun 1999; 67: 6510–6517, [PUBMED], [INFOTRIEVE], [CSA]
- Eggena M, Targan S R, Iwanczyk L, et al. Phage display cloning and characterization of an immunogenetic marker (perinuclear anti-neutrophil cytoplasmic antibody) in ulcerative colitis. J Immunol 1996; 156: 4005–4011, [PUBMED], [INFOTRIEVE]
- Dieleman L A, Pena A S, Meuwissen S G, et al. Role of animal models for the pathogenesis and treatment of inflammatory bowel disease. Scand J Gastroenterol Suppl 1997; 223: 99–104, [PUBMED], [INFOTRIEVE], [CSA]
- Kohm A P, Fuller K G, Miller S D. Mimicking the way to autoimmunity: an evolving theory of sequence and structural homology. Trends Microbiol. 2003; 11(3)101–105, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Wucherpfennig K W. Mechanisms for the induction of autoimmunity by infectious agents. J Clin Invest. 2001; 108(8)1097–1104, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Rosenbaum J T. Uveitis. An internist's view. Arch Intern Med 1989; 149: 1173–1176, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Saxon A, Shanahan F, Landers C, et al. A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol 1990; 86: 202–210, [PUBMED], [INFOTRIEVE], [CSA]
- Duerr R H, Targan S R, Landers C J, et al. Anti-neutrophil cytoplasmic antibodies in ulcerative colitis. Comparison with other colitides/diarrheal illnesses [see comments]. Gastroenterology 1991; 100: 1590–1596, [PUBMED], [INFOTRIEVE]
- Parseghian M H, Harris D A, Rishwain D R, et al. Characterization of a set of antibodies specific for three human histone H1 subtypes. Chromosoma 1994; 103: 198–208, [PUBMED], [INFOTRIEVE], [CSA]
- Parseghian M H, Clark R F, Hauser L J, et al. Fractionation of human H1 subtypes and characterization of a subtype-specific antibody exhibiting non-uniform nuclear staining. Chromosome Res 1993; 1: 127–139, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Savige J A, Paspaliaris B, Silvestrini R, et al. A review of immunofluorescent patterns associated with antineutrophil cytoplasmic antibodies (ANCA) and their differentiation from other antibodies. J Clin Pathol 1998; 51: 568–575, [PUBMED], [INFOTRIEVE]
- Dubinsky M C, Ofman J J, Urman M, et al. Clinical utility of serodiagnostic testing in suspected pediatric inflammatory bowel disease. Am J Gastroenterol 2001; 96(3)758–765, [PUBMED], [INFOTRIEVE]
- McCannel C A, Holland G N, Helm C J, et al. Causes of uveitis in the general practice of ophthalmology. UCLA Community-Based Uveitis Study Group. Am J Ophthalmol 1996; 121: 35–46, [PUBMED], [INFOTRIEVE], [CSA]